Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 3, 1996, Pages 409-424

  Livermore, D M ^a   Yuan, M ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; BETA LACTAMASE; BIAPENEM; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BELGIUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME SYNTHESIS; EUROPE; FRANCE; GERMANY; GREECE; INTENSIVE CARE; ITALY; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; NONHUMAN; PORTUGAL; SPAIN; TURKEY (REPUBLIC); UNITED KINGDOM;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CEFTAZIDIME; CEPHALOSPORINS; CLAVULANIC ACID; CLAVULANIC ACIDS; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; EUROPE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TESTS; MONOBACTAMS; PENICILLANIC ACID; PIPERACILLIN;

EID: 0029819620     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.3.409     Document Type: Article

References (6)

1. Acar, J. F., Goldstein F. W. & Kitzis, M. D. (1993). Susceptibility survey of piperacillin alone and in the presence of tazobactam. Journal of Antimicrobial Chemotherapy 31, Suppl. A, 23-8.
2. Akova, M., Yang, Y. & Livermore, D. M. (1990). Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I β-lactamases. Journal of Antimicrobial Chemotherapy 25, 199-208.
3. Angehrn, P. & Gutknecht, E. M. (1995). Bridged β-lactam Ro 48-1256. Antibacterial activity in combination with cephalosporins and imipenem. In Programe and Abstracts of the Thirty-Fifth Interscience Conference of Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract F148, p. 138. American Society for Microbiology, Washington DC.
4. Bauernfeind, A. (1990). Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third-generation cephalosporins. Infection 18, 48-52.
5. Brun-Buisson, C., Legrand, P., Philippen, A., Montravers, F., Ansquer, M. & Duval, J. (1987). Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii, 302-6.
6. Bush, K., Jacoby, G. A. & Medeiros, A. A. (1995). A functional classification scheme for β-lactamases and its corelation with molecular structures. Antimicrobial Agents and Chemotherapy 39, 1211-33.